
Sign in to view content
Geographic Atrophy in the Canadian Treat and Extend Trial With Ranibizumab in nAMD Patients: CANTREAT Study 24-Month Results
- Video
- Published 2019
Peter J. Kertes, MD, FRCS(C)
AMD Neovascular Part II Symposium
Related
Category: AMD-Neovascular